Butterfly Network, Inc. (NYSE: BFLY) posts $32.6 million quarterly revenue, exceeding guidance and representing 39% year-over-year growth. This strong revenue growth signals a positive trend for investors, with shares rising 117.9% year-to-date.

Key Highlights

  • BFLY reports quarterly revenue of $32.6 million, up 39% year-over-year
  • Gross margin increases to 71.4%, with gross profit of $23.3 million
  • Adjusted EBITDA loss improves 78% to $1.4 million
  • Insider activity indicates recent share transactions by officers and directors

Butterfly Network, Inc. (NYSE: BFLY) announced its latest quarterly results, showing revenue of $32.6 million, a 39% increase compared with the same period last year. The company’s strong revenue performance reflects continued adoption of its handheld ultrasound devices across a broadening patient base. This momentum reinforces confidence in the firm’s strategic focus on portable imaging solutions within the evolving healthcare environment.

Quarterly Results Breakdown

Revenue of $32.6 million represents a notable jump from the prior‑year figure of $23.4 million. Gross margin rose to 71.4%, delivering gross profit of $23.3 million. Operating expenses amounted to $37.0 million, reflecting a 19% increase over the comparable prior‑year period.

Adjusted EBITDA loss narrowed to $1.4 million, marking a 78% improvement and signaling a positive trend in profitability metrics. These outcomes stem from ongoing product innovation, expanded distribution channels, and strategic partnerships that are driving higher unit sales and broader market reach.

Market Performance and Trends

The company’s shares have shown strong price appreciation throughout the year, supported by the impressive revenue growth and margin expansion. While specific share price levels are not disclosed here, the market’s response underscores investor optimism about the firm’s positioning in the fast‑growing ultrasound segment. The broader healthcare sector continues to experience heightened demand for cost‑effective, point‑of‑care imaging technologies, a trend that aligns well with Butterfly’s value proposition.

Future Outlook and Catalysts

Butterfly Network has updated its fiscal‑year revenue guidance to a range of $119 million to $123 million, indicating anticipated growth of roughly 22% to 26% versus the prior year. The company also forecasts an adjusted EBITDA loss between $19 million and $23 million for the full year. Looking ahead to the next quarter, revenue is projected to fall within the $26 million to $30 million bracket, with expectations of continued negative adjusted EBITDA reflecting ongoing investment in expansion initiatives.

Upcoming milestones, including the release of new device models, further international market penetration, and additional partnership announcements, are expected to serve as catalysts for continued performance improvement.

Overall, Butterfly Network’s solid top‑line growth, enhanced gross margins, and narrowing EBITDA losses position the company favorably as it seeks to capitalize on the expanding demand for portable diagnostic imaging solutions.

Peers Moving on This News

  • Ekso Bionics Holdings Inc (CHRN) up 5.6%
  • Transmedics Group Inc (TMDX) up 0.6%
  • Pulse Biosciences Inc (PLSE) little changed

Analysis based on the Form 8-K filed 30 July 2026; figures verified against the filing and live market data.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.